Utepreva Introduces FDA 510(k)-Cleared Endometrial Sampler Designed to Support Early Detection of Endometrial Cancer

Utepreva LLC today announced the launch of the Utepreva Endometrial Sampler, a patented, FDA 510(k)-cleared, single-use endometrial sampling device engineered to enhance tissue capture and support ...
Health And Pharma

FDA-Cleared Utepreva Device Aims to Improve Early Endometrial Cancer Detection

The FDA 510(k)-cleared Utepreva Endometrial Sampler, a single-use device designed to support early diagnostic evaluation of ...
Healio

ACOG updates guidance for evaluating postmenopausal bleeding

ACOG issued updated guidance recommending endometrial tissue sampling as well as transvaginal ultrasonography when initially ...
Healio

Model predicts endometrial hyperplasia, cancer risk in women with abnormal uterine bleeding

Please provide your email address to receive an email when new articles are posted on . Age, nulliparity, polyps and shorter sampling intervals may predict endometrial hyperplasia and cancer. Risk ...
Medscape

Tampon-Based Test Detects Endometrial Cancer Using Vaginal Fluid Biomarkers

The Mayo Clinic and Exact Sciences are developing an easy, noninvasive test to detect endometrial cancer in women with abnormal vaginal bleeding. It analyzes vaginal fluid collected on tampons for ...
ascopubs.org

Feasibility of vaginal tampon versus swab in the collection of vaginal fluid for endometrial cancer testing.

Clinicopathological features and risk factors of type 1 and type 2 endometrial cancer: A retrospective single-centre analysis. Median (IQR) for RM1 and 8 MDMs by case/control and sampling technique.
Healthline

Ultrasound Screening Often Misses Endometrial Cancer in Black Females

Share on Pinterest A common ultrasound screening technique used to assess the risk of endometrial cancer may be less effective in Black females, a new report suggests. MoMo Productions/Getty Images A ...